PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform

PerkinElmer, a leading global analytical services and solutions provider, announces that it has acquired Covaris, a leading developer of solutions to empower life science innovations. The merger will accelerate Covaris’ growth potential and expand PerkinElmer’s existing life sciences portfolio into the high-growth diagnostics end market. Both companies are majority owned by New Mountain Capital, and terms of the transaction were not disclosed. As precision medicine gathers pace for personalized disease treatment and prevention, Covaris is ideally positioned to help enable and accelerate the next generation of life sciences innovation, especially through its Next-Generation Sequencing (NGS) capability, for efficient, reproducible and high-throughput sample preparation and data analysis.

Read the full article: PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform //

Source: https://www.businesswire.com/news/home/20231201756145/en/PerkinElmer-Acquires-Covaris-to-Create-an-Innovation-Led-Global-Life-Sciences-and-Diagnostics-Platform

Leave a Comment

Your email address will not be published.

Scroll to Top